[1]
Repetto, F. et al. 2023. Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study. Acta Dermato-Venereologica. 103, (Apr. 2023), adv5278. DOI:https://doi.org/10.2340/actadv.v103.5278.